Astrazeneca AZN
NYSE AZN
$163.70 +3.53 (+2.20%)
As of: Sep 14, 2026 · 3:05 PM EDT

Astrazeneca (AZN) Operating Income Growth (5y) (2014 - 2026)

Analysis

Astrazeneca (AZN) Operating Income Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Asml Holding 618.78 Bn 602.80 Bn 5.90 Bn
2 Hsbc Holdings 362.62 Bn 362.62 Bn -
3 General Electric 329.79 Bn 320.45 Bn 6.95 Bn
4 Astrazeneca 253.78 Bn 248.49 Bn 12.86 Bn
5 Citigroup 228.38 Bn -2,073.93 Bn 24.75 Bn
6 Bhp 216.07 Bn 197.52 Bn -
7 Rio Tinto 203.71 Bn 199.33 Bn -
8 Diageo 197.09 Bn 195.06 Bn -
9 Unilever 139.31 Bn 132.28 Bn -
10 Hdfc Bank 117.84 Bn 80.69 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.93%
Mar 31, 2026 17.51%
Dec 31, 2025 14.90%
Sep 30, 2025 25.07%
Jun 30, 2025 22.26%
Mar 31, 2025 24.67%
Dec 31, 2024 5.07%
Sep 30, 2024 22.71%
Jun 30, 2024 40.98%
Mar 31, 2024 23.21%
Dec 31, 2023 45.23%
Sep 30, 2023 18.09%
Jun 30, 2023 26.34%
Mar 31, 2023 29.64%
Dec 31, 2022 31.16%
Sep 30, 2022 1.62%
Jun 30, 2022 -10.24%
Mar 31, 2022 -0.87%
Dec 31, 2021 -17.27%
Sep 30, 2021 -29.40%